Immediate, complete, and sustained inhibition of C5 with ALXN1210 reduces complement-mediated hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH): Interim analysis of a dose-escalation study

Authors
Category Primary study
JournalBlood
Year 2016
This article has no abstract
Epistemonikos ID: dcbae076d8d0c09e566e535d46ae20314d6fac3c
First added on: Feb 08, 2025